Temporal trends in rates of infection-related hospitalisations in Hong Kong people with and without diabetes, 2001–2016: a retrospective study

[1] Kornum JB(2008)Diabetes, glycemic control, and risk of hospitalisation with pneumonia: a population-based case-control study Diabetes Care 31 1541-1545

[2] Thomsen RW(2020)Trends in rates of infections requiring hospitalisation among adults with versus without diabetes in the U.S., 2000-2015 Diabetes Care 43 106-116

[3] Riis A(2018)Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study Diabetes Care 41 513-521

[4] Lervang HH(2007)Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome Diabetologia 50 549-554

[5] Schønheyder HC(2003)Quantifying the risk of infectious diseases for people with diabetes Diabetes Care 26 510-513

[6] Sørensen HT(2015)Excess risk of dying from infectious causes in those with type 1 and type 2 diabetes Diabetes Care 38 1274-1280

[7] Harding JL(2006)Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS Diabet Med 23 623-628

[8] Benoit SR(2020)Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Lancet Respir Med 8 475-481

[9] Gregg EW(2008)Hyperglycaemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia Blood 112 82-89

[10] Pavkov ME(1997)Impaired leucocyte functions in diabetic patients Diabet Med 14 29-34

[1] Kornum JB(2008)Diabetes, glycemic control, and risk of hospitalisation with pneumonia: a population-based case-control study Diabetes Care 31 1541-1545

[2] Thomsen RW(2020)Trends in rates of infections requiring hospitalisation among adults with versus without diabetes in the U.S., 2000-2015 Diabetes Care 43 106-116

[3] Riis A(2018)Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study Diabetes Care 41 513-521

[4] Lervang HH(2007)Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome Diabetologia 50 549-554

[5] Schønheyder HC(2003)Quantifying the risk of infectious diseases for people with diabetes Diabetes Care 26 510-513

[6] Sørensen HT(2015)Excess risk of dying from infectious causes in those with type 1 and type 2 diabetes Diabetes Care 38 1274-1280

[7] Harding JL(2006)Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS Diabet Med 23 623-628

[8] Benoit SR(2020)Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Lancet Respir Med 8 475-481

[9] Gregg EW(2008)Hyperglycaemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia Blood 112 82-89

[10] Pavkov ME(1997)Impaired leucocyte functions in diabetic patients Diabet Med 14 29-34